Renocare Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2009.
2009 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Renocare Pharmaceuticals Private Limited

Renocare Pharmaceuticals Private Limited, a active private limited company, was established on 26 June 2009 in Chennai, Tamil Nadu, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230TN2009PTC072103. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.80 M and a paid-up capital of ₹1.67 M.

It upholds a compliant status. Employing 120 professional, Its leadership includes Tiruvallur Echambadi Asshok Iyengar (Managing Director), Vividh Ashok Tiruvallur Echambadi (Director), Ashok Iyengar Harrsha (Director). Past directors included Cootam Raman Padmalatha, Vividh Ashok Tiruvallur Echambadi, Ashok Iyengar Harrsha. It holds ₹2.39 Cr open charges and ₹4.00 M settled loans. Its latest AGM occurred on 21 August 2025, with the balance sheet filed on 31 March 2025. It is based at Plat No.Rf-6, I Floor,Abhi-Ani Terrace, Plot No.22,Gangai Amman Koil Iv Street,, Vadapalani, Chennai, Tamil Nadu, 600026.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TN2009PTC072103

  • Registration Number

    072103

  • Incorporation Date

    26 June 2009

  • Authorized Capital

    ₹1.80 M

  • Paid-Up Capital

    ₹1.67 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.80 M
  • Paid Up Capital ₹ 1.67 M
  • Company Age 16 Year, 7 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 2.39 Cr
  • Satisfied Charges ₹ 4.00 M
  • Revenue Growth **** 14.23%
  • Profit Growth **** -25.49%
  • Ebitda **** -31.09%
  • Net Worth 65.14%
  • Total Assets **** 23.68%
Company report

Renocare Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Renocare Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Renocare Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Tiruvallur Echambadi Asshok Iyengar Managing Director 04 Sep 2016 Current
Vividh Ashok Tiruvallur Echambadi Director 21 Sep 2022 Current
Ashok Iyengar Harrsha Director 21 Sep 2022 Current
Ashok Hemma Director 18 Apr 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 12 Jul 2023 Past
Pramod Abcsdd Director 05 Apr 2018 Past
Pramod Abcsdd Director 05 Apr 2018 Past
Pramod Abcsdd Director 12 Jul 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Renocare Pharmaceuticals.

Renocare Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.23% increase. The company also saw a substantial fall in profitability, with a 25.49% decrease in profit. The company's net worth Soared by an impressive increase of 65.14%.

Renocare Pharmaceuticals revenue growth over time
Renocare Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 14.23%
*******
*******
*******
*******
Revenue from Operations
*******
 14.03%
*******
*******
*******
*******
Total Assets
*******
 23.68%
*******
*******
*******
*******
Profit or Loss
*******
 -25.49%
*******
*******
*******
*******
Net Worth
*******
 65.14%
*******
*******
*******
*******
EBITDA
*******
 -31.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Renocare Pharmaceuticals?

Unlock access to Renocare Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹23,856,916.00

Satisfied Charges

₹4,000,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 2.00 Cr
  • Hdfc Bank Limited : 0.39 Cr
Latest Charge Details
Date Lender Amount Status
11 Dec 2024 State Bank Of India ₹2.00 Cr Open
30 Oct 2023 Hdfc Bank Limited ₹2.51 M Open
14 Dec 2021 Hdfc Bank Limited ₹1.35 M Open
16 Jul 2012 Axis Bank Limited ₹4.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Renocare Pharmaceuticals?

Renocare Pharmaceuticals has a workforce of 120 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Renocare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renocare Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Renocare Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Renocare Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Aug 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Renocare Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Charges

    A charge with State Bank Of India amounted to Rs. 20.00 M with Charge ID 101027102 was registered on 11 Dec 2024. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 2.51 M with Charge ID 100848296 was registered on 30 Oct 2023. was documented.

  • Director Appointment

    Progress on Vividh Ashok Tiruvallur Echambadi was appointed as a Director was appointed as a Director on 21 Sep 2022 & has been associated with this company since 3 years 4 months . was documented.

  • Director Appointment

    The activity Ashok Iyengar Harrsha was appointed as a Director was appointed as a Director on 21 Sep 2022 & has been associated with this company since 3 years 4 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Renocare Pharmaceuticals Private Limited?

The CIN of Renocare Pharmaceuticals Private Limited is U24230TN2009PTC072103.

Where is Renocare Pharmaceuticals Private Limited headquartered?

Renocare Pharmaceuticals Private Limited is headquartered at Plat No.Rf-6, I Floor,Abhi-Ani Terrace, Plot No.22,Gangai Amman Koil Iv Street,, Vadapalani, Chennai, Tamil Nadu, 600026.

When was Renocare Pharmaceuticals Private Limited incorporated?

Renocare Pharmaceuticals Private Limited was incorporated on 26 June 2009.

Who are the current directors of Renocare Pharmaceuticals Private Limited?

The current directors of Renocare Pharmaceuticals Private Limited are

What is the primary industry of Renocare Pharmaceuticals Private Limited?

The primary industry of Renocare Pharmaceuticals Private Limited is Trade.

Is Renocare Pharmaceuticals Private Limited a listed company?

Renocare Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Renocare Pharmaceuticals Private Limited?

The authorized capital of Renocare Pharmaceuticals Private Limited is ₹1.80 M, and the paid-up capital is ₹1.67 M.

What is the compliance status of Renocare Pharmaceuticals Private Limited?

The compliance status of Renocare Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available